logo
Apple Releases iOS 18.6.1 (Blood Oxygen Returns) and a New iOS 26 Beta 6

Apple Releases iOS 18.6.1 (Blood Oxygen Returns) and a New iOS 26 Beta 6

Geeky Gadgetsa day ago
Apple has officially released iOS 18.6.1 and WatchOS 11.6.1, reactivating the blood oxygen monitoring feature for the Apple Watch Series 9, Series 10, and the Apple Watch Ultra (2nd generation) in the United States. This update resolves a prior restriction on the feature, reinstating a critical health tracking tool for users. Alongside these updates, Apple has also re-released iOS 26 Developer Beta 6 and introduced the third public beta for iOS 26, further expanding its software ecosystem and offering early access to upcoming features. The video below from iDeviceHelp gives us more details.
Watch this video on YouTube. Blood Oxygen Monitoring: What's New?
The latest updates restore the blood oxygen sensor functionality for compatible Apple Watch models in the U.S., which had been temporarily disabled due to regulatory concerns. This sensor enables you to measure your blood oxygen levels directly from your wrist, offering valuable insights into your respiratory health and overall wellness.
The data collected by the sensor integrates seamlessly with the Health app on your iPhone, providing a detailed view of trends over time. This functionality is particularly beneficial for monitoring conditions such as sleep apnea, respiratory issues, or general fitness levels. To enable this feature, you must update your Apple Watch to WatchOS 11.6.1 and your iPhone to iOS 18.6.1. Once updated, you can access comprehensive blood oxygen readings that help you track your health and potentially identify early warning signs of underlying issues. How to Update and Access the Feature
To take full advantage of the restored blood oxygen monitoring feature, follow these steps: Ensure your iPhone is updated to iOS 18.6.1. You can check for updates by navigating to Settings > General > Software Update.
Update your Apple Watch to WatchOS 11.6.1 by opening the Watch app on your iPhone and selecting General > Software Update.
Once both devices are updated, open the Health app on your iPhone to view and analyze your blood oxygen data.
This feature is particularly useful for individuals focused on proactive health management, as it provides real-time data that can assist in tracking respiratory health and overall wellness. Whether you are monitoring your fitness progress or keeping an eye on potential health concerns, this tool offers a convenient and reliable way to stay informed. iOS 26 Beta Updates: What You Need to Know
In addition to the stable updates, Apple has re-released iOS 26 Developer Beta 6 and launched the third public beta for iOS 26. These beta versions are designed for developers and early adopters who are eager to explore upcoming features before the official release.
One notable improvement is the alignment of build numbers for Developer Beta 6 and Public Beta 3, ensuring consistency across testing environments. This alignment simplifies the development process and provides a more unified experience for testers. If you're part of Apple's beta testing program, these updates offer an opportunity to preview new features, test compatibility, and provide valuable feedback to Apple. However, it's important to note that beta software may contain bugs or incomplete features, so it is recommended to install these versions on secondary devices rather than your primary ones. Health App Integration: A Holistic Approach
The reintroduction of blood oxygen monitoring underscores Apple's commitment to creating a comprehensive health tracking ecosystem. The Health app acts as a central hub, consolidating data from various sources, including blood oxygen levels, heart rate, activity metrics, and sleep patterns. This integration allows you to view all your health data in one place, making it easier to identify trends and make informed decisions about your wellness.
Apple's focus on ecosystem refinement is evident in the seamless synchronization between iOS and WatchOS. This compatibility ensures that users can enjoy a consistent and reliable experience, whether they are tracking their fitness goals, monitoring chronic conditions, or simply staying informed about their overall health. Additionally, the beta programs for iOS 26 highlight Apple's dedication to innovation, allowing developers and early adopters to contribute to the evolution of its software ecosystem. Why These Updates Matter
The release of iOS 18.6.1 and WatchOS 11.6.1 marks a significant milestone for Apple Watch users in the U.S., as it restores a key health monitoring feature that enhances the device's functionality. The ability to measure blood oxygen levels directly from your wrist is not only convenient but also a valuable tool for maintaining and improving your health. This update reinforces Apple's position as a leader in health-focused technology, offering tools that empower users to take control of their wellness.
Meanwhile, the re-release of iOS 26 Developer Beta 6 and the introduction of Public Beta 3 reflect Apple's ongoing efforts to refine its software and expand its ecosystem. These updates provide developers and early adopters with the tools they need to explore new features and contribute to the platform's growth.
By staying updated with the latest software releases, you can take full advantage of Apple's advancements in health tracking and technology integration. Whether you are a health-conscious individual seeking to optimize your wellness or a developer exploring the future of Apple's ecosystem, these updates offer a range of benefits that enhance your experience and engagement with Apple's products.
Discover other guides from our vast content that could be of interest on iOS.
Source & Image Credit: iDeviceHelp Filed Under: Apple, Apple iPhone, Top News
Latest Geeky Gadgets Deals
Disclosure: Some of our articles include affiliate links. If you buy something through one of these links, Geeky Gadgets may earn an affiliate commission. Learn about our Disclosure Policy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Using AI to analyse ultrasound scans lets parents pinpoint exact due date of babies, study claims
Using AI to analyse ultrasound scans lets parents pinpoint exact due date of babies, study claims

Daily Mail​

time4 hours ago

  • Daily Mail​

Using AI to analyse ultrasound scans lets parents pinpoint exact due date of babies, study claims

Using artificial intelligence to analyse ultrasound scans could give parents the exact day their child will be born with 95 per cent accuracy, a study has claimed. Doctors currently estimate a foetus's due date by adding 40 weeks to the first day of the mother's last menstrual period. This rough calculation is known as Naegele's rule and assumes the woman has a 28-day menstrual cycle and ovulates on day 14, which, for many, is not true. In the UK, just four per cent of babies are born on their due date. But a group of US researchers say using AI to analyse ultrasounds could predict a child's date of birth with 95 per cent accuracy. Using a software developed and trained using more than two million ultrasound images from women who gave birth at the University of Kentucky from 2017 to 2020, the scientists measured how well AI could estimate whether a baby would be carried to term or not. The program, called Ultrasound AI, was able to predict whether a baby would be born early with 72 per cent accuracy, without relying on external information such as maternal history or clinical measurements. It was 95 per cent accurate in predicting the due date of babies carried to full term, and 92 per cent accurate for all births combined. 'AI is reaching into the womb and helping us forecast the timing of birth, which we believe will lead to better prediction to help mothers across the world and provide a greater understanding of why the smallest babies are born too soon,' said Dr John O'Brien, director of maternal-foetal medicine at the University of Kentucky. 'AI will eventually provide greater insights into how to target and prevent adverse pregnancy outcomes 'This work is an important first step in the start of a powerful advance in technology for the field of obstetrics.' Preterm birth is currently the leading cause of neonatal mortality in the world, and one in every 12 babies is born prematurely. It comes after the UK Government last year announced a plan to reduce the number of preterm births from 8 per cent to 6 per cent.

Forget rows about interest rates — we should watch out for AI
Forget rows about interest rates — we should watch out for AI

Times

time5 hours ago

  • Times

Forget rows about interest rates — we should watch out for AI

The US president and the chairman of the Federal Reserve board are at swords drawn over the relation between changes in interest rates and job creation. While the president concentrates on defenestrating bureaucrats who report fewer jobs than he believes exist, and the chairman of the Fed ponders the significance of 'cracks' in the labour market, artificial intelligence is making those concerns pale into insignificance. Morgan Stanley estimates that these large models that are equipping machines to perform tasks typically associated with human intelligence will gobble $3 trillion of capital in the next three years. It is the double-digit unemployment gorilla sitting in congressional hearing rooms, in the Fed board room and at the dining table at Mar-a-Lago. Dario Amodei, CEO of Anthropic, a powerful creator of AI systems, estimates that AI will wipe out half of all entry-level white-collar jobs in the next one to five years, and drive the unemployment rate to as high as 20 per cent. Indeed, even now, recent college graduates — unemployment rate 6.5 per cent — are complaining of extreme difficulties in finding jobs. McKinsey, the management consultancy, reckons that AI could automate 30 per cent of hours currently worked across the US economy by 2030, and that 60 per cent will be significantly altered by AI tools. JPMorgan Chase CEO Jamie Dimon says: 'AI is everywhere … it hedges our equity portfolios … there's nothing it's not going to touch.' Gone will be bank tellers, data entry clerks, administrative assistants and executive secretaries. More optimistic observers point out that when Henry Ford reduced the horse from a major means of transportation to dressage, starring roles in cowboy movies, and polo, consumers wanted, then needed cars — and more than one — creating millions of jobs for auto workers and mechanics. When Thomas Alva Edison created the light bulb he relegated candlemakers to making scented gifts, while creating jobs for manufacturers of those bulbs and enabled students to engage in myriad night time activities, including, but not limited to, studying. When Steve Jobs created the iPhone and thin Macs, he replaced latter-day Bob Cratchits with spread sheets, and AT&T repairmen with programmers and manufacturers of computers, carrying cases, ergonomic chairs. The supply of each invention created its own demand, along with the burning desire for their add-ons. Apple AirPods, anyone? We do not yet know whether the beneficent effects of this new force will be outweighed by its ability to seize control of its creators. But the speed with which AI is penetrating almost every phase of economic life, and uncertainty about just what products it will create or make newly affordable for consumers, make it unwise to mumble something about the historic fecklessness of Luddites and do nothing. The potential transition costs will be too high, the potential strains on society and the pressures on politicians too great for a policy of benign neglect. Imagine this: in the morning strange metal objects directed by AI 'agents', software systems capable of planning and reasoning, are directing machines, usually robots, that are mowing your lawn and cleaning your pool. An AI agent-directed drone has deposited the book you ordered on your doorstep after an AI-directed robot selected it from the bottom of a pile in a huge warehouse. You enter an AI- directed driverless car that delivers you to your golf club while you adjust the Metaglasses that have replaced iPhones and read news reports written by an AI agent specially for you, based on your recent purchases, travels, conversations at home and other personal data sprinkled by you across the internet. No waiting for a sci-fi future; it has arrived. The question, where have all the workers gone? The answer, AI agents have replaced them, every one. Some experts, including Jamie Dimon, believe the past is prologue: AI will create more jobs than it will destroy, proving John Maynard Keynes right again when he wrote almost 100 years ago, that 'technological unemployment … is only a temporary phase of maladjustment.' Possible. But even so, there will be high transition costs for which policies must be thought through before the full blast of AI makes itself felt. Government budgets already under strain will make it difficult to supplement the incomes of displaced workers, at a time when an ageing population places greater demand on the existing social safety net. Past efforts at retraining programmes have largely failed, and must be reshaped. Taxes will be needed to transfer some of the benefits of AI to the adversely affected. But without destroying incentives to retrain and find work, as would a universal basic income — no work required — being mooted by some guilt-ridden Silicon Valley magnates. Add measures that provide incentives to accelerate the development of new products and the consequent new jobs for humans, and the higher incomes capable of financing the amelioration of the costs of change. Make fast write-offs of research and development costs and investment a permanent feature of the tax code. I leave the question of regulating scams, abuses, of what Amodei calls 'extreme blackmail behaviour' and robots that are capable of assassinating their creators to others. irwin@ Irwin Stelzer is a business adviser

Mounjaro is a taste of the battle to come over drug prices
Mounjaro is a taste of the battle to come over drug prices

Times

time7 hours ago

  • Times

Mounjaro is a taste of the battle to come over drug prices

I t turns out that weight-loss drugs don't shrink everything. Take the bestseller Mounjaro, produced by Eli Lilly. Its weekly injection can help patients shed the pounds, but the price is getting fatter. Last week, the US pharmaceutical giant announced that the cost of getting Mounjaro in the UK privately will rocket by up to 170 per cent. Why the super-sized price hike? It's because US President Donald Trump believes other developed countries are paying too little for their drugs, and is pressing companies to equalise prices. Unlike in free-market America, many countries impose price controls on medicines. In the UK, the cost effectiveness of new drugs is judged by Nice, an independent body, and the price is negotiated by the NHS, which is known for driving a hard bargain. There are similar arrangements in other countries.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store